Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives.
about
Seronegative antibody-mediated neurology after immune checkpoint inhibitors.Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap.The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disordersNeurological complications of immune checkpoint inhibitors: what happens when you 'take the brakes off' the immune systemCarnosol Modulates Th17 Cell Differentiation and Microglial Switch in Experimental Autoimmune Encephalomyelitis
P2860
Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives.
@en
Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives.
@nl
type
label
Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives.
@en
Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives.
@nl
prefLabel
Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives.
@en
Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives.
@nl
P2860
P1476
Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives.
@en
P2093
Lidia M Yshii
Reinhard Hohlfeld
P2860
P2888
P304
P356
10.1038/NRNEUROL.2017.144
P407
P50
P577
2017-11-06T00:00:00Z